Viagen Pets and Equine is a biotechnology company that will produce genetic twins of customers' pets and livestock. But its conservation efforts are what attracted Colossal.
Colossal Biosciences has expanded its efforts to save animals currently on the brink with its acquisition of the cloning ...
How they’re doing it: The new company, called Preventive, is being formed to research so-called “heritable genome editing,” ...
Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...
Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
Colossal’s purchase of ViaGen, known for cloning pets of celebrities, bolsters the biotech firm’s tools for de-extinction and ...
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement ...
State Key Laboratory for Quality and Safety of Agro-Products, Key Laboratory of Biotechnology in Plant Protection of MARA, Zhejiang Key Laboratory of Green Plant Protection, Institute of Plant ...
NEW YORK — There is new hope for the families of hundreds of Sept. 11 victims whose remains were never identified, according to the city medical examiner, who sent letters on Thursday saying an ...